第十一批国家药品集采中选产品价差缩小;荃信生物与罗氏达成授权交易 | 医药早参

每日经济新闻
Oct 29

丨2025年10月29日星期三丨  NO.1 第十一批国家药品集采共纳入55种药品  10月28日,第十一批国家组织药品集中带量采购公布中选结果。此次集采共纳入55种药品,覆盖抗感染、抗过敏、抗肿瘤、降血糖、降血压、降血脂等领域常用药品,总体实现了“稳临床、保质量、反内卷、防围标”预期目标。中选产品平均价差较此前批次明显缩小。  点评:本次集采竞争激烈程度远高于前十批集采,但通过1亿元以下规模产品...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10